Literature DB >> 23048205

Fatty acid and very low density lipoprotein metabolism in obese African American and Caucasian women with type 2 diabetes.

Bernard V Miller1, Bruce W Patterson, Adewole Okunade, Samuel Klein.   

Abstract

Type 2 diabetes mellitus (T2DM) is associated with increased plasma triglyceride (TG) concentrations, but African Americans (AA) have lower plasma TG than Caucasians (CC). We evaluated the hypothesis that obese AA women have lower plasma TG than obese CC women do because of differences in lipid kinetics. Eleven AA and 11 CC obese women with T2DM, matched on body mass index (BMI) (AA = 37 ± 1, CC = 37 ± 1 kg/m(2)), age, duration of diabetes, percentage body fat, and insulin sensitivity (S(I), determined by an intravenous glucose tolerance test), were studied. Plasma TG concentration (AA = 1.14 ± 0.11, CC = 1.88 ± 0.18 mmol/l), FFA rate of appearance (R(a)) into plasma (AA = 419 ± 27, CC = 503 ± 31 µmol·min(-1)), and total VLDL-TG secretion rate (AA = 18 ± 2, CC = 29 ± 4 µmol·min(-1)) were lower in AA than CC women (all P < 0.05). In contrast, plasma total apolipoprotein (apo)B-100 concentration (AA = 1,542 ± 179, CC = 1,620 ± 118 nmol/l) and VLDL-apoB-100 secretion rate (AA = 1.3 ± 0.1, CC = 1.3 ± 0.1 nmol·min(-1)) were similar in both groups, so the molar ratio of VLDL-TG secretion rate to VLDL-apoB-100 secretion rate was lower in AA women than in CC women. VLDL-TG concentration was lower in AA women due to lower total VLDL-TG secretion rate. However, the VLDL-apoB-100 secretion rate was the same in both groups, demonstrating that AA women secrete smaller VLDL particles containing less TG than do CC women.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23048205      PMCID: PMC3494253          DOI: 10.1194/jlr.P030593

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  32 in total

1.  Use of stable isotopically labeled tracers to measure very low density lipoprotein-triglyceride turnover.

Authors:  Bruce W Patterson; Bettina Mittendorfer; Nizar Elias; Raj Satyanarayana; Samuel Klein
Journal:  J Lipid Res       Date:  2002-02       Impact factor: 5.922

Review 2.  Dual-energy X-ray absorptiometry and body composition: differences between devices and comparison with reference methods.

Authors:  Laurence Genton; Didier Hans; Ursula G Kyle; Claude Pichard
Journal:  Nutrition       Date:  2002-01       Impact factor: 4.008

3.  Racial differences in lipid metabolism in women with abdominal obesity.

Authors:  S B Racette; J F Horowitz; B Mittendorfer; S Klein
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2000-09       Impact factor: 3.619

4.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

5.  Levels and correlates of LDL and VLDL particle sizes among children: the Bogalusa heart study.

Authors:  D S Freedman; B A Bowman; J D Otvos; S R Srinivasan; G S Berenson
Journal:  Atherosclerosis       Date:  2000-10       Impact factor: 5.162

6.  Differences in the lipolytic function of adipose tissue preparations from Black American and Caucasian women.

Authors:  Hisham Barakat; Robert C Hickner; Jonathan Privette; Joseph Bower; Enhui Hao; Vidya Udupi; Allan Green; Walter Pories; Ken MacDonald
Journal:  Metabolism       Date:  2002-11       Impact factor: 8.694

7.  Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans.

Authors:  A Katz; S S Nambi; K Mather; A D Baron; D A Follmann; G Sullivan; M J Quon
Journal:  J Clin Endocrinol Metab       Date:  2000-07       Impact factor: 5.958

8.  Dyslipidaemia in African Americans, Hispanics and whites with type 2 diabetes mellitus and hypertension.

Authors:  M D Sharma; V N Pavlik
Journal:  Diabetes Obes Metab       Date:  2001-02       Impact factor: 6.577

9.  The pattern of dyslipidemia among urban African-Americans with type 2 diabetes.

Authors:  C B Cook; D M Erdman; G J Ryan; K J Greenlund; W H Giles; D L Gallina; I M El-Kebbi; D C Ziemer; K L Ernst; V G Dunbar; L S Phillips
Journal:  Diabetes Care       Date:  2000-03       Impact factor: 19.112

10.  Differences in the relation of obesity to serum triacylglycerol and VLDL subclass concentrations between black and white children: the Bogalusa Heart Study.

Authors:  David S Freedman; Barbara A Bowman; James D Otvos; Sathanur R Srinivasan; Gerald S Berenson
Journal:  Am J Clin Nutr       Date:  2002-05       Impact factor: 7.045

View more
  9 in total

1.  VLDL Triglyceride Kinetics in Lean, Overweight, and Obese Men and Women.

Authors:  Bettina Mittendorfer; Mihoko Yoshino; Bruce W Patterson; Samuel Klein
Journal:  J Clin Endocrinol Metab       Date:  2016-09-02       Impact factor: 5.958

2.  Maternal Glucose and Fatty Acid Kinetics and Infant Birth Weight in Obese Women With Type 2 Diabetes.

Authors:  W Todd Cade; Rachel A Tinius; Dominic N Reeds; Bruce W Patterson; Alison G Cahill
Journal:  Diabetes       Date:  2016-02-09       Impact factor: 9.461

3.  Mechanism of the Inhibitory Effects of Eucommia ulmoides Oliv. Cortex Extracts (EUCE) in the CCl 4 -Induced Acute Liver Lipid Accumulation in Rats.

Authors:  Chang-Feng Jin; Bo Li; Shun-Mei Lin; Raj-Kumar Yadav; Hyung-Ryong Kim; Han-Jung Chae
Journal:  Int J Endocrinol       Date:  2013-08-20       Impact factor: 3.257

4.  Racial differences between African-American and white women in insulin resistance and visceral adiposity are associated with differences in apoCIII containing apoAI and apoB lipoproteins.

Authors:  Liyun Wang; Frank M Sacks; Jeremy D Furtado; Madia Ricks; Amber B Courville; Anne E Sumner
Journal:  Nutr Metab (Lond)       Date:  2014-12-17       Impact factor: 4.169

5.  Black African men with early type 2 diabetes have similar muscle, liver and adipose tissue insulin sensitivity to white European men despite lower visceral fat.

Authors:  Oluwatoyosi Bello; Cynthia Mohandas; Fariba Shojee-Moradie; Nicola Jackson; Olah Hakim; K George M M Alberti; Janet L Peacock; A Margot Umpleby; Stephanie A Amiel; Louise M Goff
Journal:  Diabetologia       Date:  2019-02-06       Impact factor: 10.122

Review 6.  Emerging Evidence of Pathological Roles of Very-Low-Density Lipoprotein (VLDL).

Authors:  Jih-Kai Huang; Hsiang-Chun Lee
Journal:  Int J Mol Sci       Date:  2022-04-13       Impact factor: 6.208

7.  Ethnic differences in ApoC-III concentration and the risk of cardiovascular disease: No evidence for the cardioprotective role of rare/loss of function APOC3 variants in non-Europeans.

Authors:  Madhusmita Rout; Megan Lerner; Piers R Blackett; Marvin D Peyton; Stavros Stavrakis; Evgeny Sidorov; Dharambir K Sanghera
Journal:  Am Heart J Plus       Date:  2022-03-31

Review 8.  The Pathogenic Role of Very Low Density Lipoprotein on Atrial Remodeling in the Metabolic Syndrome.

Authors:  Hsiang-Chun Lee; Yi-Hsiung Lin
Journal:  Int J Mol Sci       Date:  2020-01-30       Impact factor: 5.923

9.  Differences in gut microbiome by insulin sensitivity status in Black and White women of the National Growth and Health Study (NGHS): A pilot study.

Authors:  Candice A Price; Guillaume Jospin; Kristy Brownell; Jonathan A Eisen; Barbara Laraia; Elissa S Epel
Journal:  PLoS One       Date:  2022-01-19       Impact factor: 3.752

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.